Decreased appetite was the most frequently reported AE in the FAERS database, including exenatide (n = 6,125, 58.61%), dulaglutide (n = 2,331, 48.09%), liraglutide (n = 1,174, 41.05%), semaglutide (n = 1,377, 47.40%), and tirzepatide (n = 550, 50.51%), with the exception that it is also one of the therapeutic effects of GLP-1 RAs, therefore, decreased appetite was analyzed only at the HLT level (Supplementary Table S2)
Hopefully the iron & folate tablets will help, just unsure what to do about my injections
I've lost about 7.7% of original weight now
Always consult your OB-GYN before taking any allergy medications during pregnancy
This product is supplied exclusively for scientific laboratory research and analytical purposes
It is unevenly distributed between tissues and organs, with 80% present in muscle, and 510% present in the gastrointestinal tract